5000962022-04-012022-06-305000962022-06-305000962022-04-012022-06-30in-bse-fin:OtherExpenses1Member5000962022-04-012022-06-30in-bse-fin:OtherExpenses2Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments1Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments2Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments3Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments4Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments5Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments1Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments2Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments3Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments4Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments5Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments1Member5000962022-06-30in-bse-fin:ReportableSegments1Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments2Member5000962022-06-30in-bse-fin:ReportableSegments2Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments3Member5000962022-06-30in-bse-fin:ReportableSegments3Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments4Member5000962022-06-30in-bse-fin:ReportableSegments4Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments5Member5000962022-06-30in-bse-fin:ReportableSegments5Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments1Member5000962022-06-30in-bse-fin:ReportableSegments1Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments2Member5000962022-06-30in-bse-fin:ReportableSegments2Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments3Member5000962022-06-30in-bse-fin:ReportableSegments3Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments4Member5000962022-06-30in-bse-fin:ReportableSegments4Member5000962022-04-012022-06-30in-bse-fin:ReportableSegments5Member5000962022-06-30in-bse-fin:ReportableSegments5Member5000962022-04-012022-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15000962022-04-012022-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500096DABURNOTLISTEDINE016A01026DABUR INDIA LIMITEDEquity2022-04-012023-03-312022-08-042022-06-29INRCroresFirst quarterMulti segment2022-08-0412:00:002022-08-0414:25:00Not applicable2022-04-012022-06-30UnauditedConsolidated28224300000100550000029229800000137398000002530100000-9888000002698900000121500000676000000480770000023585200000564460000005644600000120840000022200000123060000004414000000000-34000004410600000-6838000003726800000440320000074000003729300000-2500000177170000012.492.48002.492.480.00120.29940.5302Consolidated Notes: <BR> <BR> 1.The unaudited consolidated financial results of the Company for the quarter ended 30 June 2022 have been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 04 August 2022. The statutory auditors have expressed an unmodified opinion in the review report on these consolidated financial results. <BR> <BR> 2.The Company has outstanding unsecured non-convertible debentures (NCDs) amounting to Rs 250.00 crores which will mature on 21 October 2024. The NCDs are listed on National Stock Exchange of India Limited (NSE). The assets cover exceeds 100% of the principal amount of NCDs as at 30 June 2022. <BR> <BR> 3.During the quarter, the Company has allotted 38,71,376 equity shares of face value of Rs 1 each to the eligible employees of the Company on account of exercise of vested stock options pursuant to the Dabur Employee Stock Option Scheme. <BR> <BR> 4.Figures for the quarters ended 31 March 2022 are the balancing figures between audited figures for the full financial year and the reviewed year to date figures upto the third quarter of the financial year. <BR> <BR> 5.Subsequent to quarter ended 30 June 2022, M/s Dabur International Limited and M/s Dabur (UK) Limited, (both wholly owned subsidiaries of Dabur India Limited), have entered into an agreement to purchase 84,79,187 equity shares & 1,000 equity shares, respectively, of M/s Asian Consumer Care Private Limited (subsidiary company of Dabur India Limited) from the JV partner - M/s Advanced Chemical Industries Limited, for a consideration of BDT 60 crores ( Rs 51 crores approx.). Consequently, the group’s shareholding in M/s Asian Consumer Care Private Limited will increase from 76% to 100% and it shall become a wholly owned subsidiary company of Dabur India Limited after acquisition of shares which shall be completed post regulatory approvals. <BR> <BR> 6.The figures of the previous periods/year have been re-grouped/re-classified to render them comparable with the figures of the current period. <BR> <BR> Advertisement and publicity1572000000Others3235700000Consumer care business21359000000Food business6087800000Retail business256700000Other segments419800000Unallocated1010000002822430000028224300000Consumer care business4792600000Food business997300000Retail business-1000000Other segments45600000Unallocated05834500000121500000684000005644600000Consumer care business50034600000Food business12583000000Retail business912600000Other segments857400000Unallocated63093400000127481000000127481000000Consumer care business15502200000Food business5327800000Retail business998300000Other segments307400000Unallocated173588000003949450000039494500000Amount of items that will not be reclassified to profit and loss10400000104000003600000Amount of items that will be reclassified to profit and loss-1018200000-1018200000-327600000